CSM Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-268,258
Closed -$23.2M 427
2026
Q1
$23.2M Sell
268,258
-41,265
-13% -$3.95M 0.57% 45
2025
Q4
$29.7M Buy
309,523
+24,263
+9% +$2.36M 0.81% 34
2025
Q3
$27.2M Buy
285,260
+33,167
+13% +$3.05M 0.76% 35
2025
Q2
$22M Buy
+252,093
New +$21.4M 0.64% 40

Other funds holding MDT

CSM Advisors's MDT Position: Q2 2026 in Review

CSM Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 268,258 shares — an estimated $23.2M sold.

CSM Advisors first reported a position in MDT in Q2 2025 and held it in 4 quarters. The position peaked at $29.7M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CSM Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • CSM Advisors sold 268,258 Medtronic shares in Q2 2026, an estimated $23.2M.
  • CSM Advisors first reported a position in Medtronic in Q2 2025 and held it in 4 quarters.
  • CSM Advisors's Medtronic position peaked at $29.7M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.